News & Media

Industry news curated and delivered to inform your dealmaking strategies. We select the most relevant information, providing a consistent, convenient source for exclusive intelligence and analysis.

All News Activism Mergers & Acquisitions Podcasts Private Equity Restructuring Videos

Page 5

Mergers & Acquisitions

Social Capital SPAC Surprises With Oversized IPO

By Bill Meagher
|
Published: May 7th, 2020
Social Capital Hedosophia Holdings Corp. III responded to unusally strong investor interest by upsizing its IPO from $600 million to $720 million.
Mergers & Acquisitions

‘Coronavirus Risk’ Enters M&A Lexicon

By David Hatch
|
Published: May 5th, 2020
Uncertainty posed by the pandemic is reshaping negotiations, upending timelines, altering strategies and killing transactions.
Mergers & Acquisitions

B. Riley Registers New SPAC

By Bill Meagher
|
Published: April 29th, 2020
The Los Angeles investment bank has returned to the special purpose sector sponsoring its second SPAC, B. Riley Principal Merger Corp. II.
Activism

Oil Patch Activists Forced to Play Waiting Game

By Tom Terrarosa
|
Published: April 24th, 2020
It is unclear when commodity prices will recover, but when they do, activists will be sure to have fully sharpened blades and a list of demands for companies across the oil and gas production industry.
Mergers & Acquisitions

Shadowy ‘Team Telecom’ to Resemble Cfius

By David Hatch
|
Published: April 20th, 2020
A presidential order adds structure and deadlines to an amorphous U.S. government panel that reviews international telecom deals.
Mergers & Acquisitions

Trending: Podcast M&A

By Chris Nolter
|
Published: April 17th, 2020
Spotify, iHeartMedia, Entercom, Scripps and others have been binging on podcasts through acquisitions with goals to scale-up.
Mergers & Acquisitions

Blackstone, Alnylam Ink Collaboration Deal

By Armie Margaret Lee
|
Published: April 15th, 2020
As part of the agreement, Blackstone will pay $1 billion to purchase 50% of Alnylam’s royalties and commercial milestones for inclisiran, an investigational cholesterol treatment.
Upcoming Events
Solutions
Contact The Deal
Tel:
1-888-667-3325
International:
+1-212-224-3069
Email:
customerservice@thedeal.com
© 2020 The Deal.

A Euromoney Institutional Investor PLC business. All Rights Reserved. Privacy Policy. Modern Slavery Act. View our Terms & Conditions and Terms of Service.